Acinetobacter baumannii is a major extensively drug-resistant lethal human nosocomial bacterium. However, the host innate immune mechanisms controlling A. baumannii are not well understood. Although viewed as an extracellular pathogen, A. baumannii can also invade and survive intracellularly. However, whether host innate immune pathways sensing intracellular bacteria contribute to immunity against A. baumannii is not known. Here, we provide evidence for the first time that intracellular antibacterial innate immune receptors Nod1 and Nod2, and their adaptor Rip2, play critical roles in the sensing and clearance of A. baumannii by human airway epithelial cells in vitro. A. baumannii infection upregulated Rip2 expression. Silencing of Nod1, Nod2, and Rip2 expression profoundly increased intracellular invasion and prolonged the multiplication and survival of A. baumannii in lung epithelial cells. Notably, the Nod1/2-Rip2 axis did not contribute to the control of A. baumannii infection of human macrophages, indicating that they play cell type-specific roles. The Nod1/2-Rip2 axis was needed for A. baumannii infection-induced activation of NF-B but not mitogen-activated protein kinases. Moreover, the Nod1/2-Rip2 axis was critical to induce optimal cytokine and chemokine responses to A. baumannii infection. Mechanistic studies showed that the Nod1/2 pathway contributed to the innate control of A. baumannii infection through the production of ␤-defensin 2 by airway epithelial cells. This study revealed new insights into the immune control of A. baumannii and may contribute to the development of effective immune therapeutics and vaccines against A. baumannii.
A cinetobacter baumannii has emerged as a major antibioticresistant Gram-negative nosocomial bacterium causing high morbidity and mortality, especially in immune-suppressed patients and in wounded military personnel (1) . A. baumannii infection can cause pneumonia, bacteremia, endocarditis, skin and soft-tissue infections, urinary tract infections, and meningitis (2) . Mortality rates from A. baumannii infections range from 20 to 70% (3). With no vaccine or antimicrobials available against panresistant isolates, A. baumannii is among the six top-priority dangerous microorganisms listed by the Infectious Diseases Society of America (4) . The continuously increasing number of infections caused by multi-and pandrug-resistant strains of A. baumannii highlights the importance of development of new treatment options against this emerging infectious threat.
Despite its significant global clinical importance, A. baumannii is an understudied pathogen, with significant knowledge gaps existing in our understanding of its immune pathogenesis and host immune defense mechanisms. In particular, the role of innate immune pathways in the host defense against A. baumannii is still incomplete. Early recruitment of neutrophils to the lungs has been shown to be a critical component in the control of A. baumannii multiplication and subsequent extrapulmonary dissemination. Neutrophils (5) and other phagocytes, such as macrophages (6) , may also kill A. baumannii via generation of toxic reactive oxygen species (7) and reactive nitrogen species (6) products. In addition, the airway epithelial cells produce immune mediators such as ␤-defensin 2 (BD2) as part of the innate immune response to A. baumannii infection (8) . Consistent with its well-known extracellular life cycle and presence of lipopolysaccharide (LPS) on the cell wall, previous studies identified that toll-like receptor 4 (TLR4) is involved in immunity against A. baumannii (8-10). March et al. reported a role for both TLR4 and TLR2 in the induction of inter-
leukin-8 (IL-8) by lung epithelial cells in vitro during A. baumannii infection (8)
. Knapp et al. found that TLR4-deficient mice were more susceptible to A. baumannii infection, while TLR2-deficient mice were less susceptible (10) . Interestingly, another study that used highly virulent bacterial strains reported that TLR4-deficient mice were highly resistant to A. baumannii infection-induced mortality and had levels of tissue bacterial load similar to those of wild-type controls (11) . This observed difference in the host susceptibility between both studies was attributed to the difference in the ability of LPS shedding by the two different bacterial strains used in these studies. Yet another report showed that although deficiency of TLR4 or LPS significantly affected the innate immune response of murine macrophages/dendritic cells to A. baumannii infection, it did not abrogate it completely (12, 13) . The latter study hinted that there exist additional host innate bacterial systems that recognize and initiate immune responses against A. baumannii. Thus, the identity of the innate immune receptors and signaling pathways that are involved in the immune resistance against A. baumannii infection needs further studies.
A. baumannii is generally viewed as an extracellular bacterium, but recent reports have shown that A. baumannii can invade lung epithelial cells (14, 15) and also get internalized into macrophages (6) , indicating that this bacterium also has an intracellular life cycle. The contribution of the intracellular life cycle of A. baumannii in its pathogenesis has yet to be fully defined. In addition, this also implicates that the host immune system has to use specific immune mechanisms targeting intracellular bacterial pathogens to effectively control A. baumannii infection. However, whether intracellular pattern recognition pathways are involved in the host resistance to A. baumannii infection is not known.
The Nod-like receptors (NLRs) are exclusively cytosolic pattern recognition receptors (PRRs) expressed predominately by macrophages and dendritic and epithelial cells, and they contribute mainly to the detection of and immune response against intracellular bacterial pathogens (16) . Nod1 and Nod2 are two major members of NLRs, and they detect the pathogen-associated molecular pattern (PAMP) bacterial peptidoglycan components iE-DAP and muramyl dipeptide (MDP), respectively (17) . Ligand-activated Nod1/Nod2 associate with the adaptor protein Rip2, triggering proinflammatory signaling pathways and leading to the activation of NF-B and the mitogen-activated protein kinases (MAPKs; p38, JNK, and ERK) (18, 19) , resulting in cytokine and chemokine induction. The Nod1/2-Rip2 pathway has also been associated with the induction of type I interferon (20) , caspase-1 (21), etc. In addition, both Nod1 and Nod2 are involved in the induction of several innate bacterial killing mechanisms, such as autophagy, free radical production, and antibacterial peptide production (22) . The Nod1/2-Rip2 pathway plays an essential role in the immunity to many intracellular pulmonary pathogens, such as Listeria monocytogenes (23) , Legionella pneumophila (24) , Chlamydophila pneumoniae (25) , and Mycobacterium tuberculosis (20) .
The reported ability of A. baumannii to colonize intracellular environments raises the possibility that host innate immune pathways detecting intracellular bacteria play a role in the immune control of the infection by this bacterium. Given the fact that the cell wall of A. baumannii contains peptidoglycan, it is reasonable to hypothesize a role for the NLRs Nod1 and Nod2 and its adaptor Rip2 in the immune recognition and defense against A. baumannii. Accordingly, in this study we identified a prominent, novel involvement of the intracellular innate immune signaling pathway comprised of Nod1, Nod2, and Rip2 in immunity against A. baumannii infection of lung epithelial cells.
MATERIALS AND METHODS
Cells, plasmids, and reagents. Human lung A549 epithelial cells (ATCC CCL185), HEK293T (ATCC CRL11268), and human monocytic cell line THP-1 (ATCC TIB-202) were purchased from the ATCC. Primary normal human bronchial epithelial cells (NHBE) were purchased from Lonza (CC-2540). pCDNA 3.1 plasmid expressing Rip2, Nod2, and Nod1 (hemagglutinin [HA] tagged) was a gift from G. Nunez (University of Michigan). pGL3 plasmid containing 2,338 bp of the human BD2 (hBD2) promoter (hBD2-luciferase plasmid) was a kind gift from Jurgen Harder (University Hospital, Kiel, Germany) (26) . The sources and catalogue numbers of other reagents used in this study are the following: antibodies to Rip2 (SC-22763) and NEMO (IKK␥) (SC-8339) were procured from Santa Cruz; Nod2 antibody was purchased from Cayman Chemicals (160777); phosphospecific antibodies for IkB␣ (Ser32) (14D4) (2859), p44/p42 MAPK (Erk1/2) (9106), and p38 MAPK (9211) were from Cell Signaling Technology; horseradish peroxidase (HRP)-linked anti-rabbit IgG (7074) and HRP-linked anti-mouse IgG (7076) were procured from Cell Signaling Technology; glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-HRP-linked antibody was procured from GeneScript; protein G beads (SC2002) were from Santa Cruz; MDP (tlrl-mdp) and iE-DAP(tlrl-dap) were from Invivogen; and enzyme-linked immunosorbent assay (ELISA) kits for IL-8 (550999) and tumor necrosis factor alpha (TNF-␣) (550610) were from BD Biosciences. Also used were the transfection reagents Lipofectamine 2000 (11668-019; Invitrogen), Dharmafect 1 (T-2001-03; Dharmacon), Dual-Glo luciferase assay reagent (E2920; Promega), and TransIT-TKO reagent (MIR 2150, Mirus). Cell culture media were purchased from Invitrogen. Blood agar and LuriaBertani broth were purchased from Sigma. Nod2-deficient mice and control mice in the C57BL/6 background were obtained from Jackson Laboratories and were described before (27) .
A. baumannii propagation. A. baumannii ATCC 19606 T was used in this study. Bacteria were maintained in blood agar plates, cultured overnight in LB at 37°C, and used for in vitro infection experiments.
Cell culture and A. baumannii infections in vitro. Human lung epithelial cells (A549; ATCC CCL185) and HEK293T cells were maintained in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum (FBS) medium; THP-1 cells (ATCC TIB-202) were maintained in Roswell Park Memorial Institute (RPMI) medium with 10% FBS medium, and primary NHBE were grown in bronchial epithelial cell basal medium with growth supplements (Lonza). Bone marrow-derived macrophages from Nod2-deficient mice were isolated and cultured as described before (28) . Briefly, bone marrow was collected from the femur and tibia of 6-to 8-week-old wild-type and Nod2
Ϫ/Ϫ mice. The bone marrow cells were cultured in Dulbecco's modified Eagle medium (10% fetal calf serum, penicillin, streptomycin, HEPES, sodium pyruvate, ␤-mercaptoethanol) in the presence of 100 ng/ml murine macrophage colony-stimulating factor (M-CSF) for 6 to 7 days to differentiate into bone marrow-derived macrophages. Prior to infection with bacteria, the cells were washed with phosphate-buffered saline (PBS). Bacteria grown overnight were harvested by centrifugation (3,000 ϫ g, 8 min), washed twice with PBS, and resuspended in the respective medium prior to infection. Heat-killed A. baumannii cells were prepared by exposure of bacteria to 80°C for 90 min. Infections were performed at a multiplicity of infection (MOI) of 100 bacteria per cell as described before (14) . To synchronize entry, the bacteria were centrifuged at 600 ϫ g for 5 min. Following 2 h of incubation with bacteria, the cells were washed thrice with PBS and treated with media containing 200 g/ml gentamicin for another 2 h to kill extracellular bacteria. Following 2 h of gentamicin treatment, the cells were washed thrice with PBS and either lysed in PBS containing 0.1% Triton X-100 and plated on LB agar plates to assess invasion (by calculating the CFU) or maintained in medium with 10 g/ml gentamicin for various times.
qRT-PCR analysis. RNA was isolated from A. baumannii-infected cells using an RNeasy kit (Qiagen), and cDNA was made using an iSCRIPT kit (Bio-Rad) according to the manufacturer's instructions. Rip2 levels were determined by SYBR green dye-based quantitative real-time PCR (qRT-PCR) with primers detecting Rip2 and normalized with human ␤ actin gene. Rip2 was amplified using the following primers: Rip2F, 5=-CCATCCCGTACCACAAGCTC-3=; and Rip2R, 5=-GCAGGATGCG GAATCTCAAT-3=. The primers used for amplifying the human ␤ actin gene were ActinF (5=-TGATATCGCCGCGCTCGTCGTC-3=) and ActinR (5=-GCCGATCCACACGGAGTACT-3=).
Gene silencing. Gene silencing in A549 cells was done using Dharmafect 1 lipid transfection reagent according to the manufacturer's instructions. Fifty nM the respective small interfering RNAs (siRNAs) was used for the knockdown assay. Forty-eight h following gene knockdown, cells were infected with bacteria for various times. Gene silencing in NHBE cells was done using a nucleofection strategy (4D-nucleofector system; Lonza) according to the manufacturer's instructions. Gene silencing in THP-1 cells was done using TransIT-TKO reagent from Mirus according to the manufacturer's protocol. Briefly, siRNA targeting Nod1, Nod2, or Rip2 was transfected using TransIT-TKO reagent into THP-1 cells grown in a 48-well plate (2.5 ϫ 10 5 cell/well) for 48 h. At 36 h following knockdown, the cells were exposed to 100 ng/ml PMA (phorbol myristate acetate) to induce differentiation for 18 h. After the differentiation, the cells were infected with A. baumannii (MOI, 100) for various times. The siRNA sequences used were Rip2 si-1 (5=-GGAAUUAUCUCUGAACAUA-3=), Rip2 si-2 (5=-GAAAGGAUGUCUUAAGAGA-3=), NOD1si (5=-AAGAG CCTCTTTGTCTTCACC-3=), and NOD2si (5=-AAGACATCTTCCAGT TACTCC-3=). Pooled Rip2 siRNA (Rip2 si-1 and Rip2 si-2) was used for the experiments. The siRNAs were synthesized by SABio (Singapore). Nontargeting siRNA from Dharmacon was used as the negative control.
Measurement of cytokines. The culture supernatants collected at various time points were stored at Ϫ80°C until ELISA was done. The protein standards and antibody pairs for IL-8 and TNF-␣ were purchased from eBioscience. ELISAs for cytokine measurement were performed as described previously (29) .
Plasmid transfections and luciferase assay. Plasmid transfections in A549 cells were done using Lipofectamine 2000 transfection reagent according to the manufacturer's instructions. Five hundred ng of HAtagged Rip2 was used for Rip2 overexpression studies to determine whether Rip2 can enhance cellular resistance to A. baumannii infection. Twenty-four h after transfection, a bacterial infection assay was performed and cells were lysed 24 h after infection to determine intracellular bacterial load. For luciferase assays, HEK293T cells were transfected with NF-B-luciferase/hBD2-luciferase plasmids, Renilla luciferase plasmid, and Nod1/Nod2 expression constructs. For hBD2-luciferase assays, A549 cells were first transfected with 100 nM each siRNAs, viz., nontargeting siRNA control (siNT), siNod1, siNod2, or in combination (siNod1ϩsiNod2), as described above. Thirty-six h following gene knockdown, cells were transfected separately with reporter plasmids encoding hBD2-luc (500 ng) or B-luc (500 ng). Twenty-four h following transfection, the cells were infected with A. baumannii for another 7 h and a luciferase assay was performed by lysing the cells in passive lysis buffer (Promega). Luciferase activity was calculated using a dual-luciferase assay activity kit (Promega) according to the manufacturer's instructions. Firefly luciferase values were normalized to those for Renilla luciferase.
IP and immunoblot analysis. For immunoprecipitation (IP) assays, A549 cells were either stimulated with MDP (10 g/ml) and iE-DAP (10 g/ml) or infected with A. baumannii (MOI, 100) for the indicated time intervals. The cells were gently washed with ice-cold 1ϫ PBS and lysed in 1ϫ IP lysis buffer (Cell Signaling) including 1ϫ protease inhibitors, 1 mM sodium vanadate, and 1 mM phenylmethylsulfonyl fluoride and incubated on ice for 30 min. The cells were centrifuged at 13,000 rpm for 15 min at 4°C. The clarified supernatants (100 g of each) were incubated with 1 g of anti-Rip2 overnight at 4°C, followed by further incubation with protein G beads for 4 h. The immune complexes were washed with 1 ml of lysis buffer three times with 10 min of incubation and subjected to immunoblot analysis with the indicated antibodies. The membranes were reprobed with different antibodies per the standard protocol.
Western blotting. For Western blotting, the treated cells were lysed in ice-cold lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1% Triton X-100, 1 mM EGTA) with protease and phosphatase inhibitors (Pierce Biotech) for 20 min, and the clarified lysate was separated by 12% denaturing SDS-polyacrylamide gel electrophoresis. Western blotting was performed on the separated proteins transferred to nitrocellulose membranes (Bio-Rad) using standard procedures. The signal was developed using an ECL Western kit (GE Healthcare).
Statistical analysis. Data are presented as means Ϯ standard deviations (SD). We performed statistical analysis by using an unpaired Student's t test. P values of Յ0.05 were considered statistically significant.
RESULTS
A. baumannii infection upregulates Rip2 expression. Because A. baumannii can invade host cells, we reasoned that its infection modulates the intracellular antibacterial defense mechanisms. We first investigated whether A. baumannii infection leads to the transcriptional induction of Rip2, the common adaptor protein for the intracellular receptors Nod1 and Nod2. For this study, we used human lung epithelial cell line A549, which was previously shown to be susceptible to intracellular infection by A. baumannii. We infected human lung epithelial cell line A549 with A. baumannii and measured the expression levels of Rip2 using qRT-PCR. Notably, we observed that there was a 3-fold increase (P Ͻ 0.05) in the transcription of Rip2 at 4 h postinfection with A. baumannii (Fig. 1A) in lung epithelial cells.
Rip2 is important for the innate immune control of A. baumannii cellular infection in vitro. Because A. baumannii infection upregulated Rip2 transcription and Rip2 is known to mediate immunity to intracellular bacterial pathogens, we hypothesized that Rip2 plays roles in the immune control of A. baumannii infection. We first determined the infection kinetics of A549 cells by A. baumannii. It was found that the intracellular A. baumannii levels in A549 cells increased between 4 h postinfection and 24 h postinfection. However, there was a major reduction in the number of bacteria that remained viable at 48 and 72 h (Fig. 1B) . To investigate the role of Rip2 in the immune response to A. baumannii, we silenced Rip2 expression in A549 cells using siRNA and assessed the effect of Rip2 depletion on intracellular bacterial levels using a CFU assay. As shown in Fig. 1C , gene silencing was successful. Remarkably, repression of Rip2 expression led to a significant change in the cellular susceptibility to A. baumannii infection compared to that of negative-control siRNA-treated cells. As shown in Fig. 1D , Rip2 gene silencing resulted in up to 3.5-, 5.5-, and 27.5-fold increases in the intracellular bacterial load at 4, 24, and 48 h postinfection, respectively.
We next aimed to determine the earliest stage and time of infection at which Rip2-mediated immunity was involved in the cellular defense against A. baumannii infection. For this, we assessed the effect of Rip2 depletion on the entry of A. baumannii into lung epithelial cells. Interestingly, the absence of Rip2 expression significantly affected A. baumannii infection levels in A549 cells as early as 30 min postinfection (Fig. 1D) , indicating that bacterial entry itself is enhanced by the absence of Rip2 expression. We also used primary human bronchial epithelial cells (NHBE) to validate the role of Rip2 in the innate immune control of A. baumannii infection. Rip2 was first silenced in NHBE cells by using siRNA, and then gene-silenced cells were infected with A. baumannii (MOI, 100) for 2 h. Following gentamicin treatment to kill extracellular bacteria, the infection was allowed to continue for 24 h. As seen in Fig. 1E , Rip2 depletion caused a significant increase (2.1-fold) in the intracellular bacterial levels by CFU assay. Gene silencing was confirmed by measuring Rip2 transcript levels by qRT-PCR (see Fig. S1A in the supplemental material).
Because ablation of expression of Rip2 made lung epithelial cells more susceptible to infection, we wondered whether enhanced expression of Rip2 makes these cells more resistant to A. baumannii infection. For this, A549 cells were transfected with an Rip2 expression plasmid containing the Rip2 gene for 24 h and were challenged with A. baumannii infection. Twenty-four h later, the intracellular bacterial levels were assessed using CFU assay. Indeed, as predicted, we found that ectopic expression of Rip2 made lung cells more resistant to A. baumannii infection. Figure  1F shows that there was a 1.9-fold reduction in the intracellular bacterial numbers when Rip2 was ectopically expressed. Collectively, these studies revealed that Rip2 is an important component of the defense against A. baumannii, even during very early stages of infection.
Rip2 is required for A. baumannii-induced NF-B activation in lung epithelial cells. Rip2 mediates innate immune responses through the activation of NF-B and MAP kinase signaling. Since A. baumannii infection was previously shown to activate both NF-B and MAP kinase signaling pathways (10), we wondered whether Rip2 plays any role in their activation during A. baumannii infection. To study this, Rip2-silenced A549 cells were infected with A. baumannii for various times, and the activation of NF-B and MAP kinases was assessed by measuring the phosphorylated levels of IB␣, p38, and Erk1/2. As shown in Fig. 2A (upper) , our results identified that Rip2 was essential for activation of NF-B during A. baumannii infection. Densitometry-based analysis found that the absence of Rip2 expression reduced the level of phosphorylated IB␣ essentially to that of the noninduced state ( Fig. 2A, lower) . On the other hand, we found that Rip2 did not play any major role in A. baumannii infection-induced activation of MAP kinases ( Fig. 2A, upper) . These data showed that Rip2 is critical for A. baumannii-induced activation of NF-B in lung epithelial cells.
Rip2 mediates A. baumannii-induced cytokine and chemokine responses in lung cells. Activation of Rip2 leads to secretion of several mediators of innate and adaptive immune responses. Prominent among them are cytokines and chemokines. A. baumannii infection is known to cause specific cytokine and chemokine responses. For example, IL-8 is a key chemokine released by A. baumannii-infected airway epithelial cells that is required for the activation and recruitment of neutrophils to the sites of infection (8) . We subsequently investigated whether Rip2 is involved in the cytokine response to A. baumannii infection. For investigating this, we infected Rip2-silenced A549 cells with A. baumannii and determined the levels of cytokines and chemokines secreted into culture supernatant. A. baumannii infection of negative-control siRNA-treated cells led to enhanced secretion of cytokines and chemokines, such as TNF-␣ and IL-8. Strikingly, silencing of Rip2 led to a significant reduction in the production of chemokine (IL-8) (Fig. 2B ) and cytokine (TNF-␣) (Fig. 2C) during A. baumannii infection. There was up to 3.6-fold and 2.8-fold attenuation of IL-8 and TNF-␣ secretion, respectively, during A. baumannii infection. These data indicate that Rip2 is a key component in the cytokine and chemokine response to A. baumannii infection of A549 cells. Previous reports have shown the importance of TLR4 and TLR2 signaling pathways in the IL-8 response to A. baumannii infection (8) . In order to directly compare the relative contribution of TLRs and NLRs in IL-8 production during A. baumannii infection, we also silenced TLR4 and TLR2 in A549 cells and measured the IL-8 levels following infection. Figure 2B shows that silencing of TLR4 and TLR2 leads to a 4.4-and 1.7-fold reduction, respectively, in the IL-8 response during A. baumannii infection. These results show that both TLRs and NLRs are important in IL-8 production during A. baumannii infection.
Nod1 and Nod2 are involved in immunity to A. baumannii infection. Our results so far revealed that Rip2 plays an important role in the immune control of intracellular A. baumannii infection. Because Rip2 mediates the immune signaling triggered when the PRRs Nod1 and Nod2 sense PAMPs, we hypothesized that these PRRs are also involved in the immune control of intracellular infection of A. baumannii. To test this, Nod1-and Nod2-silenced A549 cells were infected with A. baumannii, and the intracellular bacterial levels were assessed at various time points postinfection (0.5, 4, 24, and 48 h) using CFU assay as described earlier. Gene silencing was successful, as confirmed by RT-PCR and Western blot analysis ( Fig. 2D ; also see Fig. S1B in the supplemental material). Consistent with the effect observed with Rip2 knockdown, we observed that silencing of Nod1 or Nod2 resulted in an increase in the invasion, prolonged intracellular survival, and replication of A. baumannii in lung epithelial cells (Fig. 2E) . The intracellular bacterial load increased up to 6-, 7-, 3.9-, and 21.2-fold for Nod1 or up to 6.5-, 13-, 5-, and 40-fold for Nod2 at the tested time points 0.5, 4, 24, and 48 h postinfection, respectively.
To further validate whether A. baumannii specifically engages Nod1/2 signaling, we attempted to use reporter assay systems that specifically monitor Nod1/2-mediated NF-B activation. HEK293T cells are widely used model systems to study Nod1/2 signaling (30). HEK293T cells do not endogenously express Nod1, Nod2, TLR4, and TLR2. However, transfection of either Nod1 or Nod2 renders these cells able to respond to the corresponding ligands iE-DAP and MDP, indicating that these cells' remaining components of the Nod1/2 signaling pathway are fully functional. First, we established that A. baumannii can invade HEK293T cells (see Fig. S2 in the supplemental material). We next aimed to explore this system to study the specific engagement of Nod1 and Nod2 by A. baumannii. HEK293T cells were cotransfected with an NF-B-dependent luciferase reporter, Renilla luciferase, and Nod1 or Nod2 expression plasmids. Twenty-four h later, cells were infected with A. baumannii for a further 7 h and the luciferase assay was performed. It was observed that control empty vectortransfected HEK293T cells did not show any notable activation of NF-B luciferase reporter when infected with A. baumannii, indicating that these cells do not have any innate immune pathway that robustly senses and responds to infection by this bacterium. Consistent with our results from A549 cells, as shown in Fig. 2F , A. baumannii infection induced a significant bacterial dose-dependent increase in NF-B activation in Nod1-or Nod2-expressing cells. We then investigated whether cellular invasion of A. baumannii was needed for Nod1/2-mediated NF-B activation. The cellular invasion of A. baumannii was previously shown to be sensitive to the actin depolymerization-interfering drug cytochalasin D (14) . Indeed, our results showed that intracellular bacterial invasion was essential for A. baumannii to induce Nod1/2-mediated NF-B activation. Pretreatment with cytochalasin D inhibited A. baumannii infection-induced NF-B signaling pathway activation (Fig. 2F) .
We also checked whether Nod1 and Nod2 play any role in the activation of NF-B and MAP kinase during A. baumannii infection. We observed that silencing of either one of these PRRs alone led to a reduction of A. baumannii-induced activation of NF-B but not MAP kinase (Fig. 2G) . These experiments collectively demonstrate that Nod1 and Nod2 signaling pathways play key roles in the innate immune control of A. baumannii.
A. baumannii infection promotes Nod1/2-Rip2 signalosome assembly. Upon agonist sensing, Nod1 and Nod2 associate with Rip2, leading to IKK complex activation (18, 19) . Therefore, we investigated whether A. baumannii infection activates canonical Nod1/2-Rip2 signalosome assembly. For this, A549 cells were infected with A. baumannii for various time points, and Rip2 was immunoprecipitated using Rip2 antibody and immunoblotted for Nod1, Nod2, and Nemo (IKK␥) to determine whether they interact with Rip2. The results revealed that A. baumannii infection resulted in enhanced interaction of Rip2 with Nod1, Nod2, and Nemo ( Fig. 3A and B) . This experiment confirmed that A. baumannii infection indeed promoted functional association of canonical Nod1/2-Rip2 signaling pathway components that is indicative of its activation.
Cell type-specific role of Nod1/2-Rip2 in the immune control of A. baumannii infection. Apart from lung epithelial cells, A. baumannii is also known to enter macrophages. Because Nod1 and Nod2 are also highly expressed in macrophages, we next investigated whether the Nod1/2-Rip2 pathway plays any role in the innate immune detection and clearance of A. baumannii in macrophages, similar to the case for lung epithelial cells. For this, we knocked down the expression of Nod1, Nod2, and Rip2 by siRNA in a human monocytic cell line (THP1 differentiated into macrophages). Forty-eight h following knockdown, the cells were infected with A. baumannii, and the intracellular bacterial numbers were assessed at various time points. Surprisingly, we found that depletion of none of these genes (Rip2, Nod1, or Nod2) affected the intracellular survival or multiplication of A. baumannii (Fig.  4A) . Gene silencing was confirmed by RT-PCR (see Fig. S3 in the supplemental material). To further confirm these results, we used primary mouse bone marrow-derived macrophages from mice deficient for Nod2 (the gene that showed the strongest phenotype of the three genes that were studied). As shown in Fig. 4D , genetic absence of Nod2 did not affect the intracellular levels of A. baumannii in murine macrophages. Although the Nod1/2-Rip2 pathway was dispensable for the intracellular survival of A. baumannii in macrophages, surprisingly the presence of this pathway was essential for the cytokine/chemokine response by the macrophages following infection. Levels of IL-8 (2.4-fold) (Fig. 4B) and TNF-␣ (6.7-fold) (Fig. 4C) were significantly reduced in Rip2-silenced THP1 cells following A. baumannii infection. Consistent with this, we also observed significantly reduced production of functional mouse IL-8 homologue MIP2 (2.3-fold) (Fig. 4E) and TNF-␣ (2.1-fold) (Fig. 4F ) in primary mouse bone marrow-derived macrophages from mice deficient for Nod2 following A. baumannii infection. These results revealed that the Nod1/2 pathway plays a cell type-specific role in the control of intracellular A. baumannii.
Prestimulation of Nod1 and Nod2 pathway enhances the host cellular resistance to A. baumannii infection. We also investigated whether prestimulation of the NLR pathway can enhance the ability of lung epithelial cells to respond to subsequent A. baumannii infection. We addressed this question by targeting Nod1 and Nod2. For this, A549 cells were treated with various concentrations of the Nod2 ligand MDP or Nod1 ligand iE-DAP and infected with A. baumannii (MOI, 100) for 4 h. We found that prestimulation of the lung epithelial cells with MDP or iE-DAP made the cells more resistant to A. baumannii infection than untreated control cells (Fig. 5 ). There was a 3.5-fold reduction in the intracellular A. baumannii levels when the cells were treated with 10 g/ml MDP. The cells were even more resistant to infection when a higher concentration of MDP (50 g/ml) was used to prestimulate the Nod2 pathway (Fig. 5A) . Subsequently, we also tested whether pretreatment with iE-DAP (the ligand of Nod1) protects the lung epithelial cells against A. baumannii infection. It was found that similar to MDP, ie-DAP pretreatment also protected the A549 cells against A. baumannii infection (3.2-fold reduction with 10 g/ml iE-DAP) (Fig. 5B) .
Nod1/2 pathway contributes to beta defensin 2 production during A. baumannii infection. We next sought to examine the mechanism by which Nod1/2 signaling exerts its antimicrobial effect against A. baumannii infection in lung epithelial cells. Nod signaling has been shown to mediate innate immune responses to pathogens via various mechanisms. One such mechanism involves antimicrobial peptide production (e.g., ␤-defensin 2 [BD2]). 〉D2 has been reported to exhibit strong bactericidal activity even against multidrug-resistant A. baumannii (31) . Moreover, A. baumannii infection has been shown to upregulate ␤-defensin 2 levels in airway epithelial cells (8) , but the underlying mechanism/signaling pathway is not yet known. Therefore, we investigated the contribution of the Nod1/2 pathway in the production of BD2 during A. baumannii infection using a BD2 promoter reporter assay. Nod1, Nod2, or Nod1ϩNod2 gene-silenced A549 cells were transfected with reporter plasmids encoding human BD2 (hBD2) promoter-driven luciferase followed by infection with A. baumannii. Consistent with the previous reports, we found that A. baumannii infection can indeed upregulate BD2 levels in lung epithelial cells (Fig. 6A) . Strikingly, silencing of either Nod1 or Nod2 significantly inhibited the production of BD2 upon A. baumannii infection (Fig. 6A) . Moreover, this effect was additive when both Nod1 and Nod2 were silenced simultaneously. We also confirmed these results in HEK293T cells by the cotransfecting hBD2 promoter-driven luciferase reporter, Renilla luciferase, and Nod1 or Nod2 expression plasmid. Twenty-four h later, cells were infected with A. baumannii for a further 4 or 7 h and the luciferase assay was performed. Consistent with our results from A549 cells, A. baumannii infection induced a significant increase in BD2 activation in Nod1-or Nod2-expressing cells (Fig.  6B) . These data imply that at least one of the mechanisms by which Nod1/2 signaling contributes to the control of A. baumannii infection involves the production of BD2.
DISCUSSION
In this study, we identified a novel and critical role for Nod1, Nod2, and Rip2 signaling pathways in defending mammalian lung epithelial cells against intracellular invasion and survival of A. baumannii. Nod1-, Nod2-, and Rip2-deficient cells had enhanced intracellular bacterial loads compared to controls at all time points tested. We also found that pretreatment of lung epithelial cells with either the Nod2 ligand MDP or the Nod1 ligand iE-DAP made the cells resistant to A. baumannii infection, implying that Nod pathway stimulation can augment the innate immune response of the host cells.
The existence of an intracellular phase in the life cycle of A. baumannii is becoming increasingly evident. One recent study reported that certain strains of A. baumannii can persist in the mouse lungs up to 3 to 4 days following infection, which promoted subsequent extrapulmonary dissemination of the bacteria (32) . Recently, it has been demonstrated that several bacterial pathogens that were previously regarded as largely extracellular actually also have an intracellular phase in their life cycle. Examples include uropathogenic E. coli (UPEC) (33) and Campylobacter jejuni (34) . It is worth recalling that UPEC displayed a very specific pattern during its intracellular infection, with less than 10% of internalized bacteria persisting intracellularly for very long periods of time (Ͼ48 h to longer durations), potentially causing chronic or recurring infection (35) . Similarly, our data revealed that even though the intracellular A. baumannii levels in untreated control samples continuously increased until 24 h postinfection, a larger fraction of the internalized bacteria was cleared by the cells by Ն48 h. This may reflect either an inability of the invaded bacteria to successfully colonize the host cells intracellularly due to lack of genetic adaptations or an inability to escape active immune killing by host cells, although they have other needed adaptations to live intracellularly. Our results demonstrated that the latter may be the case. In a striking contrast to wild-type cells, Nod1-, Nod2-, or Rip2-silenced cells had a continuous increase in the intracellular bacterial loads beyond 24 h. These results displayed that the (no-MDP sample) or with different concentrations of the Nod2 ligand MDP (10 g/ml and 50 g/ml) (A) or Nod1 ligand iE-DAP (10 g/ml and 50 g/ml) (B) for 4 h, followed by infection with A. baumannii for 2 h and 2 h of gentamicin treatment. Cells were lysed, and the number of intracellular bacteria was calculated and is represented as CFU/ml. The results shown are expressed as means Ϯ SD from a representative experiment performed in triplicate. The statistical significance was calculated using Student's t test. *, P Ͻ 0.05; ***, P Ͻ 0.001.
absence of Nod1, Nod2, or Rip2 results in uncontrolled multiplication of bacteria in lung epithelial cells. This indicated that Nod1, Nod2, and Rip2 play major roles in preventing replication of internalized A. baumannii in the lung epithelial cells. Extrapolating further, it may be reasonable to argue that A. baumannii is capable of actively multiplying and colonizing within the cells; however, it is unable to escape the immune defense induced by the Nod1/2-Rip2 pathway. An interesting observation was that depletion of expression of the Nod1/2-Rip2 axis led to enhanced cellular entry of A. baumannii, which was observed at as early as 30 min postinfection. One possible explanation is that the basal level of expression of the Nod1/2-Rip2 pathway induces certain factors in the cell that interfere with the entry of A. baumannii.
Consistent with many other Gram-negative bacteria, LPS from A. baumannii is known to activate the CD14-TLR4 pathway, leading to the production of proinflammatory molecules via the activation of NF-B and MAP kinases. However, a recent study showed that bone marrow-derived macrophages from TLR4-deficient mice still produced significant amounts of proinflammatory cytokines (12) . In addition, although A. baumannii LPS was a potent stimulator of the TLR4 pathway (9), LPS-deficient A. baumannii was still able to stimulate macrophages (13) . These observations clearly indicate that TLR4-indepenent innate immunesensing systems act during A. baumannii infection. In this regard, our results identified that the Nod1/2-Rip2 pathway is a key mediator of the proinflammatory cytokine and chemokine response against A. baumannii infection. We found that the Nod1/2-Rip2 pathway was essential for A. baumannii-induced NF-B activation, cytokine (e.g., TNF-␣), and chemokine (e.g., IL-8, the major neutrophil chemoattractant) responses in lung epithelial cells. Since neutrophils are critical components of the host innate immune resistance to A. baumannii infection (5), it will be important to evaluate the role of the Nod1/2 pathway in neutrophil recruitment to the sites of infection, as seen for many pulmonary bacterial pathogens (25, 28) . Interestingly, the Nod1/2-Rip2 pathway was not required for A. baumannii-induced MAP kinase activation. Further studies are required to understand the functional relevance of the differential requirement of NF-B versus MAP kinase signaling by A. baumannii during intracellular infection. Since TLR4, TLR2, and Rip2 were found to be important for IL-8 production during A. baumannii infection, these pathways might play independent nonredundant roles in the innate immune response to A. baumannii infection, as seen in the case for pathogens such as Mycobacterium tuberculosis (36) . Further studies are necessary to tease out the intricate potential cross-talk and synergy that might exist between TLRs and NLRs during A. baumannii infection.
Human ␤-defensin 2 is a potent antimicrobial agent that is effective against many bacterial pathogens. A. baumannii is no exception. Previous reports have shown that BD2 is highly effective in killing A. baumannii, including multidrug-resistant strains (31) . In addition, A. baumannii is known to upregulate beta defensin 2 levels in airway epithelial cells, although the signaling pathways involved in this process are not well defined (8) . Consistent with its well-known role in the production of antimicrobial peptide, we found that the Nod1/2 pathway is crucial for the production of ␤-defensin 2 by the airway epithelial cells during A. baumannii infection. Thus, this study provides direct evidence for the first time that the Nod1/2 signaling pathway is a trigger for the production of ␤-defensin 2 during A. baumannii infection.
Macrophages have been known to play an important role in the early host response to A. baumannii infection through phagocytosis and killing of bacteria as well as secretion of cytokines and chemokines. Even though A. baumannii has been shown to enter both lung epithelial cells and macrophages, the relative contribution of each of these cell types in the initial pathogen recognition, innate immune signaling, recruitment of neutrophils, and translocation of the pathogen to the circulation are still unknown. In contrast to lung epithelial cells, silencing of Nod1, Nod2, and Rip2 did not affect the intracellular survival of A. baumannii within macrophages. Interestingly, however, the levels of IL-8 and TNF-␣ were significantly reduced in macrophages depleted of Nod1, Nod2, or Rip2, implying that these NLRs contribute to the inflammatory response of macrophages to A. baumannii infection. The functional significance of this observation currently is not known. The data indicate that macrophages use the Nod1/2-Rip2 axis-independent mechanisms to kill internalized bacteria; however, macrophages use this innate pathway to elicit cytokine and chemokine responses to A. baumannii infection. Further studies are necessary to explore the underlying mechanism that kills A. baumannii in macrophages. Possible innate immune killing mechanisms include autophagy, free radical production, and antibacterial peptide production. It is also possible that certain specific mediators produced exclusively by macrophages and not by the epithelial cells contribute to the difference in their ability to mediate immune clearance of A. baumannii. Cell type-specific differences between pulmonary macrophages and epithelial cells in their production of immune mediators to mycobacterium infection have been reported before (37, 38) .
In summary, this study demonstrates that Nod1, Nod2, and Rip2 are critical components in the innate immune response to A. baumannii infection in vitro. The NLRs potentially act independently or synergistically with TLRs to mount the optimal innate immune response during A. baumannii infection. Future in vivo infection studies using Nod1-, Nod2-, and Rip2-deficient mice are necessary to expand these studies. Thus, this report reveals for the first time a functional role for intracellular pattern recognition receptors in the immune control of intracellular invasion of A. baumannii.
